Answers are grounded in this paper and cite their sources.
Validation study demonstrates high stability and reproducibility of pooled in-house autoantibody quality control sera, highlighting a cost-effective quality assurance approach for primary...
BACKGROUND: This study explored the preparation and evaluation of in-house quality control (QC) materials for antinuclear antibody (ANA) and anti-double-stranded DNA antibody (anti-dsDNA) testing by indirect immunofluorescence test (IIFT), and ANA profile testing by line immunoassay (LIA), with the aim of providing a reference for other in-house QC materials. METHODS: Patient sera were pooled to prepare a QC serum positive for all targets, while sera from healthy individuals were pooled to prepare a negative control. QC materials were heat-inactivated, centrifuged, aliquoted, and stored at -20 °C. Stability was assessed at 37 °C and during long-term storage at -20 °C. Inter-vial variation was evaluated using 20 vials, and intra-vial variation was assessed by 20 replicates of one vial. RESULTS: During the 8-day 37 °C stability test, ANA and anti-dsDNA titers remained within ± 1 serial dilution of the baseline value, and all ANA profile antibodies remained within the predefined ± 20% acceptance criterion. During long-term storage, ANA and anti-dsDNA titers also remained within ± 1 serial dilution, and the CVs of all ANA profile antibodies were below 20%. Both inter-vial and intra-vial variation met predefined criteria, and all negative controls remained negative. CONCLUSIONS: The in-house QC materials showed good stability and reproducibility, with simple preparation and potential suitability for routine use in primary healthcare laboratories.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: